INTEGRATED CANCER THERAPY

Cancer Treatment

A Science-Driven Approach Combining Local Therapies & Immunotherapy

Cancer Treatment approach at SAISEI

Our clinic combines established and innovative immunotherapy techniques, including unique treatments like GcMAF therapy, developed through global research partnerships. We offer a range of scientifically-backed methods, tailored to each patient, that have proven effective alone or in combination. GcMAF therapy, a standout in our offerings, is gaining international acclaim based on extensive research and clinical trials. We provide access to a wealth of scientific literature on our website, highlighting our commitment to advancing medical knowledge and offering globally recognized treatments.

Saisei cancer therapy
CLINICAL PHILOSOPHY

Concept of Cancer therapy at SAISEI

At SAISEI, we combine local tumor-targeted therapies with immunotherapy-based approaches to build an integrated treatment plan. By pairing methods that focus on the tumor site with therapies designed to support immune activity, we aim to create a balanced approach that prioritizes effectiveness while minimizing overall burden on the patient.

Teaching the adaptive immune system to see an antigen
Adaptive immune system concept: antigen presentation and immune response
LOCAL THERAPIES

Local tumor-targeted therapies

IMMUNOTHERAPY

Immunotherapy-based approaches

GcMAF Immunotherapy

GcMAF Immunotherapy

An immunotherapy approach focused on macrophage activation, intended to support immune response mechanisms involved in recognizing and responding to abnormal cells.

GcMAF is a Gc protein-derived Macrophage Activating Factor used as part of SAISEI’s immunotherapy approach. It is available as Plasma GcMAF and Autologous GcMAF.

Originally developed for cancer treatment, GcMAF has shown effects across a wide range of immune-related and chronic conditions.

Naive T / NK cell therapy

Naive T / NK cell therapy uses peripheral blood–derived cells and is based on the concept that naive T cells are “stem cells of lymphocytes”.

In this approach, naive T cells, T cells, and NK cells are cultivated (typically ~14 days) to prepare an autologous product.

Key points:

  • Source: peripheral blood
  • Cells cultivated: naive T cells + T cells + NK cells
  • Process: ~14-day cultivation
  • Autologous product containing over 200 million cells
  • Registered medical procedure in Japan
Naive T / NK cell therapy

Autologous cancer vaccine therapy

Personalized immunotherapy prepared from a patient’s own tumor tissue (formalin-fixed and, in some cases, paraffin-embedded) to stimulate immune recognition using tumor-associated antigens.

How it’s prepared (overview)

  • Prepared after surgery using more than 2 grams of tumor tissue
  • May be combined with immune-supporting adjuvants
  • Administered by injection under medical supervision

Dietary MAF

An oral MAF-based approach intended to support immune function and assist macrophage activity as part of overall wellness and immune regulation.

Dietary MAF is recognized not only for disease support, but also for its potential role in anti-aging and longevity through immune modulation.

Dietary MAF products

P53 / PTEN Gene Therapy

A gene-therapy approach designed to address cancer-related genetic abnormalities by introducing tumor suppressor genes such as P53 (wild type) and PTEN.

Saisei’s approach uses plasmids and liposome-based delivery systems, aiming to support apoptosis, DNA repair, and cell-cycle regulation while reducing safety concerns associated with viral vectors.

  • P53: “guardian of the genome”
  • PTEN: regulator of cell growth and signaling
  • Non-viral liposome-based vector
SUPPORTIVE & INTEGRATIVE

Adjunct / supportive therapies

Coley Vaccine (Mixed Bacterial Vaccine) therapy

Also known as Coley’s Toxins / Coley Fluid (CF) — an immunotherapy approach originally developed by surgeon William Coley (1893). It uses a sterile preparation of inactivated bacteria to mimic a controlled immune stimulus.

Treatment overview

  • Typically given 3–5 times per week, aiming for 39.5–41°C body temperature, under qualified monitoring
  • Usually one infusion per day; ~5–6 hours per treatment day
  • Vital signs are continuously monitored by experienced medical staff
  • May be used alongside other immunotherapy approaches (e.g., GcMAF and Dietary MAF)

Low-dose option (Gentle Coley’s)

  • Lower doses with generally milder reactions and a shorter visit time (~1–2 hours)
  • Can be used before starting a regular Coley Vaccine protocol
Coley Vaccine

High-Concentration Vitamin C IV (IVC) Therapy

High-dose intravenous vitamin C to reach blood levels that are difficult to achieve by oral intake.

  • Antioxidant support, cytokine-related inflammation regulation, collagen support
  • Pro-oxidant effect at pharmacologic concentrations (proposed targeted ROS mechanism)
Vitamin C IV Therapy

Ozone Drip Therapy (Blood Cleansing / Major Autohemotherapy)

A small amount of blood is collected, mixed with a controlled dose of ozone, and returned to the body.

  • 100–200 mL of blood is withdrawn
  • Ozone is mixed with the collected blood
  • The ozonated blood is reinfused
Ozone Drip Therapy

Hyperbaric Oxygen Chamber

Pressurized air (without supplemental oxygen) to gently increase surrounding pressure while you rest.

  • Supports fatigue recovery and conditioning
  • May support tissue oxygenation and recovery processes
  • Often positioned as wellness/anti-aging supportive therapy
Hyperbaric Oxygen Chamber
Contact

Request an Appointment

Send a message and our team will get back to you.

    Request an Appointment

    Clinic

    Saisei Mirai

    Address
    9th floor, OMM Building, 1-7-31, Otemae, Chuo-ku, Osaka City, Osaka Prefecture, 540-0008
    Location
    Osaka, Japan
    error: Content is protected !!